Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

Identification of Human T-Cell Lymphotropic Virus Type 1 Pro-Invasion in Patients with β-Thalassemia Major Using TaqMan Real-Time PCR in Tonekabon, Iran

Sepideh Hamidi 1 , * , Haniyeh Bashizadeh-Fakhar 2 and Ali Nazemi 1
Authors Information
1 Department of Microbiology, Tonekabon Branch, Islamic Azad University, Tonekabon , Iran
2 Department of Laboratory Science, Chalous Branch, Islamic Azad University, Chalous, Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: May 2018, 20 (5); e59961
  • Published Online: August 11, 2018
  • Article Type: Research Article
  • Received: August 10, 2017
  • Revised: December 24, 2017
  • Accepted: January 20, 2018
  • DOI: 10.5812/zjrms.59961

To Cite: Hamidi S, Bashizadeh-Fakhar H , Nazemi A. Identification of Human T-Cell Lymphotropic Virus Type 1 Pro-Invasion in Patients with β-Thalassemia Major Using TaqMan Real-Time PCR in Tonekabon, Iran, Zahedan J Res Med Sci. 2018 ; 20(5):e59961. doi: 10.5812/zjrms.59961.

Abstract
Copyright © 2018, Zahedan Journal of Research in Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Khameneh ZR, Baradaran M, Sepehrvand N. Survey of the seroprovalence of HTLV I/II in hemodialysis patients and blood donors in Urmia. Saudi J Kidney Dis Transpl. 2008;19(5):838-41. [PubMed: 18711311].
  • 2. Azarpazhooh MR, Hasanpour K, Ghanbari M, Rezaee SA, Mashkani B, Hedayati-Moghaddam MR, et al. Human T-lymphotropic virus type 1 prevalence in northeastern Iran, Sabzevar: an epidemiologic-based study and phylogenetic analysis. AIDS Res Hum Retroviruses. 2012;28(9):1095-101. doi: 10.1089/AID.2011.0248. [PubMed: 22229796].
  • 3. Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172-6. doi: 10.1016/j.jcv.2011.07.004. [PubMed: 21840754].
  • 4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005;24(39):6058-68. doi: 10.1038/sj.onc.1208968. [PubMed: 16155612].
  • 5. Rezvan H, Abolghassemi H, Amini Kafiabad S. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfusion Med. 2007;17(6):425-33. doi: 10.1111/j.1365-3148.2007.00794.x.
  • 6. Ghaffari J, Kowsarian M, Mahdavi M, Vahid Shahi K, Rafatpanah H, Tafreshian A. Prevalence of HTLV-I Infection in Patients with Thalassemia Major in Mazandaran, North of Iran. Jundishapur J Microbiol. 2012;6(1):57-60. doi: 10.5812/jjm.4702.
  • 7. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A. 1980;77(12):7415-9. [PubMed: 6261256]. [PubMed Central: PMC350514].
  • 8. Edlich RF, Arnette JA, Williams FM. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med. 2000;18(1):109-19. [PubMed: 10645850].
  • 9. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498-9. [PubMed: 19900093].
  • 10. Monavari SH, Keyvani H, Salehi-Vaziri M, Bokharaei-Salim F. Detection of human T-cell lymphotropic virus Type-1 among patients with malignant hematological diseases in Capital of Iran, Tehran. J Gen Mol Virol. 2011;3(5):67-70.
  • 11. Karimi A, Nafici M, Imani R. Comparison of human T-cell leukemia virus type-1 (HTLV-1) seroprevalence in high risk patients (thalassemia and hemodialysis) and healthy individuals from Charmahal-Bakhtiari province, Iran. Kuwait medl j. 2007;39(3):259.
  • 12. Moradi A, Mansurian AR, Ahmadi AR, Ghaemi E, Kalavi KH, Marjani A, et al. Prevalence of HTLV-1 Antibody among Major Thalassemic Patients in Gorgan (South East of Caspian Sea). J Appl Sci. 2008;8(2):391-3. doi: 10.3923/jas.2008.391.393.
  • 13. Hedayati-Moghaddam MR, Amini AR. HTLV-1 Infection as a Serious Health Issue among Iranian Multi-Transfused Patients: Evidence from a Systematic Review and Meta-Analysis. Iran J Blood Cancer. 2015;7(2):85-94.
  • 14. Moens B, Lopez G, Adaui V, Gonzalez E, Kerremans L, Clark D, et al. Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination. J Clin Microbiol. 2009;47(11):3682-91. doi: 10.1128/JCM.00781-09. [PubMed: 19741085]. [PubMed Central: PMC2772591].
  • 15. Besson G, Kazanji M. One-step, multiplex, real-time PCR assay with molecular beacon probes for simultaneous detection, differentiation, and quantification of human T-cell leukemia virus types 1, 2, and 3. J Clin Microbiol. 2009;47(4):1129-35. doi: 10.1128/JCM.02006-08. [PubMed: 19213697]. [PubMed Central: PMC2668303].
  • 16. Jalaeikhoo H, Soleymani M, Rajaeinejad M, Keyhani M. Prevalence of Human T-lymphotropic virus type 1 (HTLV-1) Infection in Patients with Hematologic Disorders and Non-Hematologic Malignancies in a Tertiary Referral Hospital. Arch Iran med. 2017;20(4).
  • 17. Trevino A, Aguilera A, Caballero E, Benito R, Parra P, Eiros JM, et al. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain. Virol J. 2012;9:71. doi: 10.1186/1743-422X-9-71. [PubMed: 22444832]. [PubMed Central: PMC3337814].
  • 18. Barrientos A, Lopez M, Sotomayor C, Pilleux L, Calderon S, Navarrete M, et al. Prevalence of human T-cell lymphotropic virus type 1 and 2 among patients with malignant hematological diseases in south Chile. J Med Virol. 2011;83(4):745-8. doi: 10.1002/jmv.22015. [PubMed: 21328393].
  • 19. Beilke MA, Theall KP, Clayton JL, Benjamin SM, Winsor EL, Kissinger PJ. Clinical outcomes and disease progression among patients coinfected with HIV and human T lymphotropic virus types 1 and 2. Clin Infect Dis. 2004;39(2):256-63.
  • 20. Vitone F, Gibellini D, Schiavone P, D'Antuono A, Gianni L, Bon I, et al. Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results. BMC Infect Dis. 2006;6(1):41.
  • 21. Li M, Green PL. Detection and quantitation of HTLV-1 and HTLV-2 mRNA species by real-time RT-PCR. J Virol Methods. 2007;142(1-2):159-68. doi: 10.1016/j.jviromet.2007.01.023. [PubMed: 17337070]. [PubMed Central: PMC2048902].
  • 22. Andrade RG, Ribeiro MA, Namen-Lopes MS, Silva SM, Basques FV, Ribas JG, et al. Evaluation of the use of real-time PCR for human T cell lymphotropic virus 1 and 2 as a confirmatory test in screening for blood donors. Rev Soc Bras Med Trop. 2010;43(2):111-5. [PubMed: 20464136].
  • 23. Tarhini M, Kchour G, Zanjani DS, Rafatpanah H, Otrock ZK, Bazarbachi A, et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology. 2009;41(5):498-9.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments